CD28 and cancer: The aging immunity study centered on T lymphocytes found that CD28 in the peripheral blood of healthy individuals was downregulated with aging, and the activation and proliferation ability of T cells decreased correspondingly, suggesting that the decrease of immune function caused by an abnormal costimulatory signaling pathway was related to the occurrence and development of malignant tumors, and became one of the important characteristics of T cell senescence (78).